Global Anti-inflammatory Agents Market 2025 by Company, Regions, Type and Application, Forecast to 2031
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Anti-inflammatory Agents by Type
- 1.3.1 Overview: Global Anti-inflammatory Agents Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Anti-inflammatory Agents Consumption Value Market Share by Type in 2024
- 1.3.3 Software
- 1.3.4 Services
- 1.4 Global Anti-inflammatory Agents Market by Application
- 1.4.1 Overview: Global Anti-inflammatory Agents Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Pharmaceutical and Biotechnology Companies
- 1.4.3 Contract Research and Development Organizations
- 1.4.4 Others
- 1.5 Global Anti-inflammatory Agents Market Size & Forecast
- 1.6 Global Anti-inflammatory Agents Market Size and Forecast by Region
- 1.6.1 Global Anti-inflammatory Agents Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Anti-inflammatory Agents Market Size by Region, (2020-2031)
- 1.6.3 North America Anti-inflammatory Agents Market Size and Prospect (2020-2031)
- 1.6.4 Europe Anti-inflammatory Agents Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Anti-inflammatory Agents Market Size and Prospect (2020-2031)
- 1.6.6 South America Anti-inflammatory Agents Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Anti-inflammatory Agents Market Size and Prospect (2020-2031)
2 Company Profiles
- 2.1 Thermo Fisher Scientific Inc
- 2.1.1 Thermo Fisher Scientific Inc Details
- 2.1.2 Thermo Fisher Scientific Inc Major Business
- 2.1.3 Thermo Fisher Scientific Inc Anti-inflammatory Agents Product and Solutions
- 2.1.4 Thermo Fisher Scientific Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
- 2.2 Oracle Corporation
- 2.2.1 Oracle Corporation Details
- 2.2.2 Oracle Corporation Major Business
- 2.2.3 Oracle Corporation Anti-inflammatory Agents Product and Solutions
- 2.2.4 Oracle Corporation Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Oracle Corporation Recent Developments and Future Plans
- 2.3 Revvity, Inc
- 2.3.1 Revvity, Inc Details
- 2.3.2 Revvity, Inc Major Business
- 2.3.3 Revvity, Inc Anti-inflammatory Agents Product and Solutions
- 2.3.4 Revvity, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Revvity, Inc Recent Developments and Future Plans
- 2.4 Clario
- 2.4.1 Clario Details
- 2.4.2 Clario Major Business
- 2.4.3 Clario Anti-inflammatory Agents Product and Solutions
- 2.4.4 Clario Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Clario Recent Developments and Future Plans
- 2.5 Illumina, Inc
- 2.5.1 Illumina, Inc Details
- 2.5.2 Illumina, Inc Major Business
- 2.5.3 Illumina, Inc Anti-inflammatory Agents Product and Solutions
- 2.5.4 Illumina, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Illumina, Inc Recent Developments and Future Plans
- 2.6 Qiagen NV
- 2.6.1 Qiagen NV Details
- 2.6.2 Qiagen NV Major Business
- 2.6.3 Qiagen NV Anti-inflammatory Agents Product and Solutions
- 2.6.4 Qiagen NV Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Qiagen NV Recent Developments and Future Plans
- 2.7 Agilent Technologies, Inc
- 2.7.1 Agilent Technologies, Inc Details
- 2.7.2 Agilent Technologies, Inc Major Business
- 2.7.3 Agilent Technologies, Inc Anti-inflammatory Agents Product and Solutions
- 2.7.4 Agilent Technologies, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Agilent Technologies, Inc Recent Developments and Future Plans
- 2.8 IBM Corporation
- 2.8.1 IBM Corporation Details
- 2.8.2 IBM Corporation Major Business
- 2.8.3 IBM Corporation Anti-inflammatory Agents Product and Solutions
- 2.8.4 IBM Corporation Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 IBM Corporation Recent Developments and Future Plans
- 2.9 Genedata AG
- 2.9.1 Genedata AG Details
- 2.9.2 Genedata AG Major Business
- 2.9.3 Genedata AG Anti-inflammatory Agents Product and Solutions
- 2.9.4 Genedata AG Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Genedata AG Recent Developments and Future Plans
- 2.10 DNAnexus, Inc
- 2.10.1 DNAnexus, Inc Details
- 2.10.2 DNAnexus, Inc Major Business
- 2.10.3 DNAnexus, Inc Anti-inflammatory Agents Product and Solutions
- 2.10.4 DNAnexus, Inc Anti-inflammatory Agents Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 DNAnexus, Inc Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Anti-inflammatory Agents Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Anti-inflammatory Agents by Company Revenue
- 3.2.2 Top 3 Anti-inflammatory Agents Players Market Share in 2024
- 3.2.3 Top 6 Anti-inflammatory Agents Players Market Share in 2024
- 3.3 Anti-inflammatory Agents Market: Overall Company Footprint Analysis
- 3.3.1 Anti-inflammatory Agents Market: Region Footprint
- 3.3.2 Anti-inflammatory Agents Market: Company Product Type Footprint
- 3.3.3 Anti-inflammatory Agents Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Anti-inflammatory Agents Consumption Value and Market Share by Type (2020-2025)
- 4.2 Global Anti-inflammatory Agents Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
- 5.1 Global Anti-inflammatory Agents Consumption Value Market Share by Application (2020-2025)
- 5.2 Global Anti-inflammatory Agents Market Forecast by Application (2026-2031)
6 North America
- 6.1 North America Anti-inflammatory Agents Consumption Value by Type (2020-2031)
- 6.2 North America Anti-inflammatory Agents Market Size by Application (2020-2031)
- 6.3 North America Anti-inflammatory Agents Market Size by Country
- 6.3.1 North America Anti-inflammatory Agents Consumption Value by Country (2020-2031)
- 6.3.2 United States Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 6.3.3 Canada Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Anti-inflammatory Agents Market Size and Forecast (2020-2031)
7 Europe
- 7.1 Europe Anti-inflammatory Agents Consumption Value by Type (2020-2031)
- 7.2 Europe Anti-inflammatory Agents Consumption Value by Application (2020-2031)
- 7.3 Europe Anti-inflammatory Agents Market Size by Country
- 7.3.1 Europe Anti-inflammatory Agents Consumption Value by Country (2020-2031)
- 7.3.2 Germany Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 7.3.3 France Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 7.3.5 Russia Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 7.3.6 Italy Anti-inflammatory Agents Market Size and Forecast (2020-2031)
8 Asia-Pacific
- 8.1 Asia-Pacific Anti-inflammatory Agents Consumption Value by Type (2020-2031)
- 8.2 Asia-Pacific Anti-inflammatory Agents Consumption Value by Application (2020-2031)
- 8.3 Asia-Pacific Anti-inflammatory Agents Market Size by Region
- 8.3.1 Asia-Pacific Anti-inflammatory Agents Consumption Value by Region (2020-2031)
- 8.3.2 China Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 8.3.3 Japan Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 8.3.5 India Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 8.3.7 Australia Anti-inflammatory Agents Market Size and Forecast (2020-2031)
9 South America
- 9.1 South America Anti-inflammatory Agents Consumption Value by Type (2020-2031)
- 9.2 South America Anti-inflammatory Agents Consumption Value by Application (2020-2031)
- 9.3 South America Anti-inflammatory Agents Market Size by Country
- 9.3.1 South America Anti-inflammatory Agents Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Anti-inflammatory Agents Market Size and Forecast (2020-2031)
10 Middle East & Africa
- 10.1 Middle East & Africa Anti-inflammatory Agents Consumption Value by Type (2020-2031)
- 10.2 Middle East & Africa Anti-inflammatory Agents Consumption Value by Application (2020-2031)
- 10.3 Middle East & Africa Anti-inflammatory Agents Market Size by Country
- 10.3.1 Middle East & Africa Anti-inflammatory Agents Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Anti-inflammatory Agents Market Size and Forecast (2020-2031)
- 10.3.4 UAE Anti-inflammatory Agents Market Size and Forecast (2020-2031)
11 Market Dynamics
- 11.1 Anti-inflammatory Agents Market Drivers
- 11.2 Anti-inflammatory Agents Market Restraints
- 11.3 Anti-inflammatory Agents Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Anti-inflammatory Agents Industry Chain
- 12.2 Anti-inflammatory Agents Upstream Analysis
- 12.3 Anti-inflammatory Agents Midstream Analysis
- 12.4 Anti-inflammatory Agents Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our latest research, the global Anti-inflammatory Agents market size will reach USD 137160 million in 2031, growing at a CAGR of 3.9% over the analysis period.
Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain. Furthermore, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. In addition, they can provide faster relief as compared to other drugs. They are capable of lowering the levels of prostaglandins and the chemicals responsible for inflammation, thereby reducing pain and swelling. Anti-inflammatory drugs usually target the anti-inflammatory mediators or enzymes. These drugs are often used in combination of other drugs. Inflammation is the most prevalent treatable symptom among many immune and respiratory diseases.
The growth of the global anti-inflammatory agents market has been driven by factors such as increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge in adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing exponentially, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the treatment of inflammation with nonsteroidal anti-inflammatory drugs in Asia-Pacific and LAMEA are expected to drive the market growth during the analysis period. However, factors such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade) impede the market growth.
This report is a detailed and comprehensive analysis for global Anti-inflammatory Agents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-inflammatory Agents market size and forecasts, in consumption value ($ Million), 2020-2031
Global Anti-inflammatory Agents market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Anti-inflammatory Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Anti-inflammatory Agents market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-inflammatory Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-inflammatory Agents market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Oracle Corporation, Revvity, Inc, Clario, Illumina, Inc, Qiagen NV, Agilent Technologies, Inc, IBM Corporation, Genedata AG, DNAnexus, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Anti-inflammatory Agents market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Software
Services
Market segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others
Market segment by players, this report covers
Thermo Fisher Scientific Inc
Oracle Corporation
Revvity, Inc
Clario
Illumina, Inc
Qiagen NV
Agilent Technologies, Inc
IBM Corporation
Genedata AG
DNAnexus, Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anti-inflammatory Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-inflammatory Agents, with revenue, gross margin, and global market share of Anti-inflammatory Agents from 2020 to 2025.
Chapter 3, the Anti-inflammatory Agents competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Anti-inflammatory Agents market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Agents.
Chapter 13, to describe Anti-inflammatory Agents research findings and conclusion.